@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C> a ns1:ATCConcept ;
    dcterms:title "Kardiovaskulární systém"@cs,
        "CARDIOVASCULAR SYSTEM"@en ;
    skos:notation "C" .

<http://linked.opendata.cz/resource/ATC/C09> a ns1:ATCConcept ;
    dcterms:title "Léčiva ovlivňující renin-angiotenzinový systém"@cs,
        "AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM"@en ;
    skos:notation "C09" .

<http://linked.opendata.cz/resource/ATC/C09A> a ns1:ATCConcept ;
    dcterms:title "ACE inhibitory, samotné"@cs,
        "ACE INHIBITORS, PLAIN"@en ;
    skos:notation "C09A" .

<http://linked.opendata.cz/resource/ATC/C09AA> a ns1:ATCConcept ;
    dcterms:title "ACE inhibitory, samotné"@cs,
        "ACE inhibitors, plain"@en ;
    skos:notation "C09AA" .

<http://linked.opendata.cz/resource/ATC/C09AA02> a ns1:ATCConcept ;
    dcterms:title "Enalapril"@cs,
        "Enalapril"@en ;
    skos:broaderTransitive "http://linked.opendata.cz/resource/ATC/C",
        "http://linked.opendata.cz/resource/ATC/C09",
        "http://linked.opendata.cz/resource/ATC/C09A",
        "http://linked.opendata.cz/resource/ATC/C09AA" ;
    skos:notation "C09AA02" .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0331398> a ns1:Ingredient ;
    ns1:hasPharmacologicalAction "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207",
        "http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456" ;
    ns1:title "Enalapril maleate"@cs,
        "Enalapril maleate"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001207> a ns1:PharmacologicalAction ;
    ns1:description "A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.     "@en ;
    ns1:title "Inhibitory angiotenzin konvertujícího enzymu"@cs,
        "Angiotensin-converting enzyme inhibitors"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001456> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.     "@en ;
    ns1:title "Antihypertenzíva"@cs,
        "Antihypertensive agents"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0006550> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09AA02" ;
    ns1:hasIndication """- léčba hypertenze;
- léčba symptomatického srdečního selhání;
- prevence symptomatického srdečního selhání u pacientů s asymptomatickou dysfunkcí levé komory (ejekční frakce ≤ 35%).
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasPackagingSize "100"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC102998_doc" ;
    ns1:hasStrength "2.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL NOB 100X2.5MG"@cs ;
    ns1:title "ENAP 2,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0059976> a ns1:MedicinalProductPackaging ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09AA02" ;
    ns1:hasIndication """- léčba hypertenze;
- léčba symptomatického srdečního selhání;
- prevence symptomatického srdečního selhání u pacientů s asymptomatickou dysfunkcí levé komory (ejekční frakce ≤ 35%).
"""@cs ;
    ns1:hasIndicationGroup "HYPOTENSIVA"@cs ;
    ns1:hasMaximalPrice "55.7099990845"^^xsd:float ;
    ns1:hasPackagingSize "30"^^xsd:string ;
    ns1:hasRegistrationState "http://linked.opendata.cz/resource/sukl/registration-state/R" ;
    ns1:hasReimbursementAmount "18.1700000763"^^xsd:float ;
    ns1:hasResumedMarketingDate "2000-01-01"^^xsd:date ;
    ns1:hasRouteOfAdministration "Perorální podání"@cs ;
    ns1:hasSPCDocument "http://linked.opendata.cz/resource/sukl/spc/document/SPC102998_doc" ;
    ns1:hasStrength "2.5MG"^^xsd:string ;
    ns1:hasTitleSupplement "POR TBL NOB 30X2.5MG"@cs ;
    ns1:title "ENAP 2,5 MG"@cs .

<http://linked.opendata.cz/resource/sukl/medicinal-product/ENAP-2-5-MG> a ns1:MedicinalProduct ;
    ns1:hasATCConcept "http://linked.opendata.cz/resource/ATC/C09AA02" ;
    ns1:hasActiveIngredient "http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0331398" ;
    ns1:hasMedicinalProductPackaging "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0006550",
        "http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0059976" ;
    ns1:title "ENAP 2,5 MG"@cs .


